Literature DB >> 22037140

Novel attempts to optimize vagus nerve stimulation parameters on serotonin neuronal firing activity in the rat brain.

Stella Manta1, Mostafa El Mansari2, Pierre Blier3.   

Abstract

BACKGROUND: Vagus nerve stimulation (VNS) is indicated for treatment-resistant epilepsy and depression. Electrophysiologic recordings in the rat brain have shown that VNS promptly increases the firing rate of NE neurons and subsequently that of 5-HT neurons. Thus far, it appears that the standard stimulation parameters currently used in depressed patients produce an optimal activation of 5-HT neurons. OBJECTIVE/HYPOTHESIS: This study was therefore aimed at investigating additional alterations of stimulation parameters to optimize VNS efficacy to further increase 5-HT neuronal activity.
METHODS: Rats were implanted with a VNS device and stimulated for 14 days using standard (0.25 mA/20 Hz/500 microseconds/30 seconds ON-5 minutes OFF, continuously) or various stimulation parameters: extension of the OFF period (30 seconds ON every 10 to 30 minutes), the OFF and ON periods, discontinuous stimulation (12 hours per day using standard parameters), and burst stimulation modes. Rat dorsal raphe 5-HT neurons were recorded under chloral hydrate anesthesia.
RESULTS: Both 12-hour stimulation periods for 14 days, and the 30-second stimulation every 10 or 15 minutes significantly increased the firing activity of 5-HT neurons to the same extent as standard parameters while the 30-minute intervals were ineffective. Stimulations in a burst mode and the pseudo-one-pulse stimulations also significantly increased 5-HT neuronal activity.
CONCLUSIONS: These results indicate that less stimulation is sufficient to achieve the same VNS efficacy on 5-HT neuronal firing. These data may be relevant for patients using VNS because these new parameters could minimize or prevent side effects and increase battery life of the stimulator.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037140     DOI: 10.1016/j.brs.2011.04.005

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  8 in total

Review 1.  Regulation of memory - from the adrenal medulla to liver to astrocytes to neurons.

Authors:  Paul E Gold
Journal:  Brain Res Bull       Date:  2014-01-07       Impact factor: 4.077

Review 2.  The diverse role of the raphe 5-HTergic systems in epilepsy.

Authors:  He-Ming Cheng; Chen-Shu Gao; Qiu-Wen Lou; Zhong Chen; Yi Wang
Journal:  Acta Pharmacol Sin       Date:  2022-05-25       Impact factor: 6.150

Review 3.  Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems.

Authors:  Charles Rodenkirch; Jason B Carmel; Qi Wang
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

4.  Facilitative effects of VNS on the motor threshold: implications for its antidepressive mode of action?

Authors:  Helge H Müller; Udo Reulbach; Juan Manuel Maler; Johannes Kornhuber; Wolfgang Sperling
Journal:  J Neural Transm (Vienna)       Date:  2013-06-05       Impact factor: 3.575

5.  Central mechanisms of cranial nerve stimulation for epilepsy.

Authors:  Erika E Fanselow
Journal:  Surg Neurol Int       Date:  2012-10-31

Review 6.  Targeted Vagus Nerve Stimulation for Rehabilitation After Stroke.

Authors:  Navzer D Engineer; Teresa J Kimberley; Cecília N Prudente; Jesse Dawson; W Brent Tarver; Seth A Hays
Journal:  Front Neurosci       Date:  2019-03-29       Impact factor: 5.152

7.  Chronic abdominal vagus stimulation increased brain metabolic connectivity, reduced striatal dopamine transporter and increased mid-brain serotonin transporter in obese miniature pigs.

Authors:  Charles-Henri Malbert; Mickael Genissel; Jean-Louis Divoux; Christine Henry
Journal:  J Transl Med       Date:  2019-03-12       Impact factor: 5.531

8.  Effects of acute transcutaneous vagus nerve stimulation on emotion recognition in adolescent depression.

Authors:  Julian Koenig; Peter Parzer; Niklas Haigis; Jasmin Liebemann; Tamara Jung; Franz Resch; Michael Kaess
Journal:  Psychol Med       Date:  2019-12-10       Impact factor: 7.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.